Retinal Consultants of America

Retinal Consultants of America (RCA) is a preeminent national network of retina specialists, operating as a physician-led management services organization. Established in 2020 through a partnership with Webster Equity Partners, RCA consolidates elite retina practices across the United States to enhance clinical excellence and operational efficiency. The company is a major player in ophthalmic clinical research, utilizing its extensive network to conduct high-impact Phase 1 through Phase 3 clinical trials for global pharmaceutical and biotechnology firms. RCA's platform provides member practices with robust administrative support, advanced imaging technologies, and a unified infrastructure for developing next-generation treatments for retinal diseases. By focusing exclusively on the retina sub-specialty, RCA aims to accelerate the delivery of innovative therapies for conditions such as macular degeneration and diabetic eye disease.